Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.
2.

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.

Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.

BJU Int. 2009 Feb;103(4):475-9. doi: 10.1111/j.1464-410X.2008.08011.x. Epub 2008 Oct 6.

3.

Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.

J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.

PMID:
18801529
4.

Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.

Lee SE, Jeong IG, Ku JH, Kwak C, Lee E, Jeong JS.

Urology. 2004 May;63(5):873-7; discussion 877.

PMID:
15134968
5.

Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.

Wasco MJ, Daignault S, Bradley D, Shah RB.

Hum Pathol. 2010 Feb;41(2):163-71. doi: 10.1016/j.humpath.2009.07.015. Epub 2009 Oct 1.

PMID:
19800100
6.

Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.

Shah RB, Montgomery JS, Montie JE, Kunju LP.

Urol Oncol. 2013 Nov;31(8):1650-5. doi: 10.1016/j.urolonc.2012.04.009. Epub 2012 May 17.

PMID:
22608543
7.

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.

Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.

J Urol. 2009 Dec;182(6):2625-30. doi: 10.1016/j.juro.2009.08.083. Epub 2009 Oct 17.

PMID:
19836779
8.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
9.

Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.

Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI.

Urology. 2010 Feb;75(2):376-81. doi: 10.1016/j.urology.2009.10.018.

PMID:
20022091
10.

Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.

Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, Lerner SP, Sagalowsky AI, Shariat SF; Bladder Cancer Research Consortium.

Urology. 2008 Feb;71(2):302-7. doi: 10.1016/j.urology.2007.10.041.

PMID:
18308108
11.

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.

J Urol. 2007 Dec;178(6):2308-12; discussion 2313. Epub 2007 Oct 22.

PMID:
17936804
12.

Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.

Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S.

Urol Oncol. 2014 Feb;32(2):117-27. doi: 10.1016/j.urolonc.2012.08.017. Epub 2013 Mar 7.

PMID:
23477878
13.

Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.

Smaldone MC, Jacobs BL, Smaldone AM, Hrebinko RL Jr.

Urology. 2008 Sep;72(3):613-6. doi: 10.1016/j.urology.2008.04.052. Epub 2008 Jun 13.

PMID:
18554696
14.

Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.

Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB.

Am J Surg Pathol. 2010 Jun;34(6):792-9. doi: 10.1097/PAS.0b013e3181da7650.

PMID:
20421781
15.

[Radical cystectomy in the treatment of bladder cancer always in due time?].

May M, Braun KP, Richter W, Helke C, Vogler H, Hoschke B, Siegsmund M.

Urologe A. 2007 Aug;46(8):913-9. German.

PMID:
17676301
16.

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6.

17.

Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.

Chang BS, Kim HL, Yang XJ, Steinberg GD.

Urology. 2001 Jun;57(6):1063-6; discussion 1066-7.

PMID:
11377305
18.

Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.

Chen W, Luo JH, Hua WF, Zhou FJ, Lin MC, Kung HF, Zeng YX, Guan XY, Xie D.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):400-8. doi: 10.1158/1055-9965.EPI-08-0754. Epub 2009 Jan 20.

19.

The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

Antunes AA, Nesrallah LJ, Dall'Oglio MF, Maluf CE, Camara C, Leite KR, Srougi M.

Int Braz J Urol. 2007 May-Jun;33(3):339-45; discussion 346.

20.

Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.

Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Am J Clin Pathol. 2000 Feb;113(2):275-9.

PMID:
10664630

Supplemental Content

Support Center